SOURCE: Clinical Ink

Clinical Ink

October 05, 2015 12:43 ET

Clinical Ink Appoints Jeffrey S. Payne as Chief Financial Officer

WINSTON-SALEM, NC and PHILADELPHIA, PA--(Marketwired - October 05, 2015) - Clinical Ink, the pioneering provider of purpose-built eSource and patient engagement solutions for clinical trials, today announced Jeffrey S. Payne as Chief Financial Officer (CFO). In this role, Payne will lead Clinical Ink's financial operations, accounting, risk management and business planning. He will report directly to Clinical Ink CEO, Ed Seguine.

Payne joins Clinical Ink from CRF Health, where he helped lead the company through a rapid growth phase as CFO. During his tenure, CRF Health grew significantly and was named to the Deloitte Fast 500 list three years in a row. Payne also helped with the successful sale of the company to Vitruvian Partners in January 2015. Payne brings more than 20 years of experience in finance, accounting, tax, mergers and acquisitions, along with a solid understanding of the life sciences industry.

"I couldn't be more thrilled to welcome Jeff to Clinical Ink where he will undoubtedly make an immediate impact as we continue our rapid growth," said Ed Seguine, CEO, Clinical Ink. "I am particularly impressed with Jeff's ability to lead a financial function that drives rapid growth, while maintaining an unrelenting focus on serving and advocating for his company and customers."

Prior to CRF Health, Payne was CFO of TRANZACT where he oversaw the sale of TRANZACT to new private equity firms, negotiated an $80 million credit facility, and reorganized the legal structure to increase tax efficiency. Prior to TRANZACT, he was co-founder and CFO of The Credo Group, where he handled all accounting, finance, human resources, legal and administration.

"I can't imagine a more exciting time to join Clinical Ink," said Payne. "Ed and his executive team recognize and appreciate they're making history by revolutionizing clinical research, and I'm delighted to be part of it."

About Clinical Ink

Founded in 2007, Clinical Ink is dedicated to transforming clinical development -- from Start to Submit™ -- by creating a completely paperless clinical trial platform for sites, sponsors, CROs and patients. Clinical Ink's SureSource platform is purpose-built to capture eSource data and documents electronically at the site, while the CentrosHealth patient engagement platform provides patients with a variety of configurable apps to keep them informed, involved and compliant throughout the duration of a clinical trial. Clinical Ink maintains offices in Winston-Salem, NC; Philadelphia, PA; Cambridge, MA and Cary, NC. Additional information is available online at www.clinicalink.com or toll-free 1-800-300-5033.

Image Available: http://www.marketwire.com/library/MwGo/2015/10/5/11G066341/Images/JPAYNE_CFO-PR_OCT2015-616191876205.jpg

Contact Information